🔎 Trials Near Me

Akèy › Miasteni grav › North Carolina › Durham

Etid klinik pou Miasteni grav nan Durham, NC

10 etid pou Miasteni grav ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Ap rekriteEtid obsèvasyon
  • Duke Early Phase Clinical Research Unit - PPDS, Durham
  • University of North Carolina at Chapel Hill-170 Manning Dr., Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07294170

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Ap rekriteFaz 2
  • Duke Early Phase Clinical Research Unit - PPDS, Durham
  • University of North Caroline at Chapel Hill-170 Manning Dr, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07284420

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Ap rekriteFaz 3
  • UNC Hospitals - PARENT, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06463587

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

Ap rekriteFaz 2
  • The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06414954

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Ap rekriteFaz 3
  • Site Number - 1013, Durham
  • Site Number - 1020, Chapel Hill · 10 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Jul 30, 2026 · NCT07039916

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Ap rekriteFaz 3
  • Duke University School of Medicine, Durham
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04951622

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

Ap rekriteFaz 3
  • University of North Carolina Hospitals - Neurology Clinic, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT06456580

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Ap rekriteEtid obsèvasyon
  • Clinical Trial Site, Durham
  • Clinical Trial Site, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 18, 2026 · NCT04202341

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

Ap rekriteFaz 2/3
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Laj 2 a 18 · Tout sèks · Mizajou Feb 18, 2026 · NCT04833894

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

Ap rekriteVolontè an sante akeyi
  • Duke University, Durham
Laj 18 ak plis · Tout sèks · Mizajou Apr 11, 2025 · NCT05564936

Etid Miasteni grav nan lòt vil

Lòt etid nan Durham

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.